![](/img/cover-not-exists.png)
Decreased serum amyloid β1–42 autoantibody levels in Alzheimer’s disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid β1–42 peptide
Sylvia Brettschneider, Nils G. Morgenthaler, Stefan J. Teipel, Christina Fischer-Schulz, Katharina Bürger, Richard Dodel, Yansheng Du, Hans-Jürgen Möller, Andreas Bergmann, Harald HampelVolume:
57
Year:
2005
Language:
english
DOI:
10.1016/j.biopsych.2004.12.008
File:
PDF, 181 KB
english, 2005